# Aarti Pharmalabs Limited, Tarapur, India – FDA Inspections

Source: https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e

> Inspection records and compliance data for Aarti Pharmalabs Limited in Tarapur. 5 FDA inspections on record, 1 Form 483, last inspected March 27, 2026.

---

## Details

- Name: Aarti Pharmalabs Limited
- FEI Number: 3005256484
- Business Operations: API MANUFACTURE
- Address Line 1: Unit IV, Plot No E-50, 50/1, 59/1, M.I.D.C. Tarapur, Taluka & District: Palghar
- City: Tarapur
- Country Name: India
- Address: Unit IV, Plot No E-50, 50/1, 59/1, M.I.D.C. Tarapur, Taluka & District: Palghar, Tarapur, India
- Country: India

## Related Documents

- [FDA Inspection 1311368 - Aarti Pharmalabs Limited - 2026-03-27](https://www.keypedia.com/records/fda_inspections/aarti-pharmalabs-limited/e91c3087-a6fe-454c-9885-8c217f044650) — source: FDA, date: March 27, 2026
- FDA Inspection 1311368 - Aarti Pharmalabs Limited - 2026-03-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 27, 2026
- [483 - Aarti Pharmalabs Limited - 2020-02-20](https://www.keypedia.com/records/483/aarti-pharmalabs-limited/b954af54-973e-4ecf-9a1e-9b2e83925926) — source: FDA, date: February 20, 2020
- FDA Inspection 1122537 - Aarti Pharmalabs Limited - 2020-02-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2020
- FDA Inspection 999203 - Aarti Pharmalabs Limited - 2016-12-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2016
- FDA Inspection 923769 - Aarti Pharmalabs Limited - 2015-03-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 27, 2015
- FDA Inspection 748221 - Aarti Pharmalabs Limited - 2011-09-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2011

## Related Companies

- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Harman Finochem Limited](https://www.keypedia.com/companies/harman-finochem-limited/7622941a-bad2-45c3-bd91-07d2bb63f905)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)

## Related Officers

- [Jason R. Caballero](https://www.keypedia.com/people/jason-r-caballero/c2c8d281-0d02-459f-9541-bc04cb6d0a59)
